Biogen Inc. (BIIB) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2024. This widely-known consensus outlook ...

Biogen BIIB and Japan-based partner, Eisai, announced an update regarding the regulatory review of an application seeking the ...

We recently compiled a list of the 12 Best S&P 500 Stocks to Invest in According to Analysts. In this article, we are going ...

Biogen (BIIB) stock in focus as company and partner Eisai (ESALF) face delay in the EU launch of Alzheimer's drug lecanemab.

Founder, Gaurab Chakrabarti, has been appointed to the Visiting Committee on Advanced Technology (VCAT) of the National Institute of Standards and Technology (NIST), part of the U.S. Department of ...

Once every four weeks maintenance dosing may be easier for patients and care partners to continue treatment Alzheimer's disease progression does not stop after plaque clearance; ongoing treatment with ...

Once every four weeks maintenance dosing may be easier for patients and care partners to continue treatment Alzheimer's disease progression does ...

RADIO AIRPLAY AUDIENCE IMPRESSIONS AS PROVIDED BY LUMINATE AND SALES DATA AS COMPILED BY LUMINATE Tyla Last week Weeks at no. 1 Weeks on chart T.L.Seethal, I.Lewis, C.M.Lindsay-Keay, A.Irosogie ...

Biogen Inc. announced that the FDA has accepted and the EMA has validated its supplemental New Drug Application for a higher dose regimen of nusinersen, intended for treating spinal muscular ...

The Cambridge drugmaker said the smaller research organization "will match the needs of a prioritized preclinical portfolio." Biogen Inc. is making cuts to its research organization as the ...

The Top Albums chart is France’s main albums chart, compiled by Official Charts Company for SNEP and SCPP, based on sales, airplay and streams in France. View the full chart here.